Drasbek M, Christiansen G, Drasbek K R, Holm A, Birkelund S
Institute of Medical Microbiology and Immunology, Bartholin Building, University of Aarhus, DK-8000 Aarhus C, Denmark.
Department of Molecular Biology, Gustav Wieds Vej 10C, University of Aarhus, DK-8000 Aarhus C, Denmark.
Microbiology (Reading). 2007 Nov;153(Pt 11):3791-3799. doi: 10.1099/mic.0.2007/010736-0.
The human pathogen Mycoplasma pneumoniae can cause atypical pneumonia through adherence to epithelial cells in the respiratory tract. The major immunogenic protein, P1, participates in the attachment of the bacteria to the host cells. To investigate the adhesion properties of P1, a recombinant protein (rP1-II) covering amino acids 1107-1518 of the P1 protein was produced. This protein inhibited the adhesion of M. pneumoniae to human HEp-2 cells, as visualized in a competitive-binding assay using immunofluorescence microscopy. Previous studies have shown that mAbs that recognize two epitopes in this region of P1 also reduce M. pneumoniae adhesion. Therefore, peptides covering these epitopes, of 8 and 13 aa, respectively, were synthesized to further investigate the adhesion region. None of these synthetic peptides reduced the binding of M. pneumoniae to the receptors on the host cells. Instead, 10 overlapping synthetic peptides covering the whole of rP1-II were evaluated in the competitive-binding assay using immunofluorescence microscopy. A reduction in the number of M. pneumoniae microcolonies was seen, which was confirmed for five peptides using a POLARstar OPTIMA reader to measure fluorescence intensity. The number of M. pneumoniae microcolonies adhering to the host cells was significantly reduced by these five peptides. Further investigations showed that inhibiting peptide 7 (amino acids 1347-1396) of the major adhesin protein P1 bound directly to host receptors, suggesting that the observed M. pneumoniae-inhibiting peptides occupied HEp-2 receptors, which are otherwise available for P1-mediated M. pneumoniae adhesion.
人类病原体肺炎支原体可通过黏附呼吸道上皮细胞引发非典型肺炎。主要免疫原性蛋白P1参与细菌与宿主细胞的黏附过程。为研究P1的黏附特性,制备了一种覆盖P1蛋白第1107 - 1518位氨基酸的重组蛋白(rP1-II)。在利用免疫荧光显微镜进行的竞争结合试验中,该蛋白抑制了肺炎支原体对人HEp-2细胞的黏附。先前研究表明,识别P1这一区域两个表位的单克隆抗体也能减少肺炎支原体的黏附。因此,分别合成了覆盖这些表位的8肽和13肽,以进一步研究黏附区域。这些合成肽均未降低肺炎支原体与宿主细胞受体的结合。相反,在利用免疫荧光显微镜进行的竞争结合试验中,对覆盖整个rP1-II的10个重叠合成肽进行了评估。观察到肺炎支原体微菌落数量减少,使用POLARstar OPTIMA酶标仪测量荧光强度对其中5个肽进行了验证。这5个肽显著减少了黏附于宿主细胞的肺炎支原体微菌落数量。进一步研究表明,主要黏附蛋白P1的抑制肽7(第1347 - 1396位氨基酸)直接与宿主受体结合,这表明观察到的肺炎支原体抑制肽占据了HEp-2受体,否则这些受体可用于P1介导的肺炎支原体黏附。